A pill intended for leukemia treatment may soon make a big difference for patients suffering from a variety of cancers. These drugs worked so well against leukemia that during trials, patients taking placebo pills were switched over to the real drug!
Cancer cells produce an enzyme called p110. This enzyme suppresses immunity, making it hard for the body to fight back against disease. The drug works by blocking that enzyme so the body can fight back more efficiently.
It turns out that this pill could be effective against a wider range of cancers than previously thought. Through research in mice with a variety of cancers, survival rate was greatly increased. Mouse studies indicate that this could be an effective treatment against breast cancer by not only minimizing the spread of the disease, but also by improving survival rates after removal of breast tumors!
P110 inhibitors could quickly become part of cancer treatments, as the drugs are already being successfully used on cancer patients. It will be interesting to see if administration of this drug for other types of cancer will be as successful as animal trials. Read more about it here: